Nanoparticles for nasal vaccination.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2009-02-27

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.addr.2008.09.005PMID 19121350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer.

  2009influential reference
• Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.

  2009cited by this paper
• Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.

  2008influential reference
• Surface modified liposomes for nasal delivery of DNA vaccine.

  2008influential reference
• Nanotechnology in vaccine delivery☆

  2008cited by this paper
• Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.

  2008cited by this paper
• Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.

  2008influential reference
• In vivo activity of cationic immune stimulating complexes (PLUSCOMs).

  2008cited by this paper
• Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine

  2008cited by this paper
• Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells.

  2008cited by this paper
• Design of novel polysaccharidic nanostructures for gene delivery

  2008cited by this paper
• Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori.

  2008cited by this paper
• Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.

  2008influential reference
• Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan

  2008cited by this paper
• Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes

  2008cited by this paper
• Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.

  2007cited by this paper
• Vaccine adjuvants revisited.

  2007cited by this paper
• Differential Antigen Processing by Dendritic Cell Subsets in Vivo

  2007cited by this paper
• Comparison of intranasal with targeted lymph node immunization using PR8‐Flu ISCOM adjuvanted HIV antigens in macaques

  2007cited by this paper
• Toll-free vaccines?

  2007cited by this paper
• Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2007cited by this paper
• Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

  2007influential reference
• Preparation of nanoparticles by the self-organization of polymers consisting of hydrophobic and hydrophilic segments: Potential applications

  2007cited by this paper
• N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.

  2007cited by this paper
• Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?

  2007cited by this paper
• Mucosal dendritic cells.

  2007cited by this paper
• Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration.

  2007cited by this paper
• Lipid microparticles for mucosal immunization against hepatitis B.

  2006cited by this paper
• Coincidence of different structures of mucosa‐associated lymphoid tissue (MALT) in the respiratory tract of children: no indications for enhanced mucosal immunostimulation in sudden infant death syndrome (SIDS)

  2006cited by this paper
• PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.

  2006influential reference
• A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin.

  2006cited by this paper
• A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.

  2006cited by this paper
• Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling

  2006cited by this paper
• Immunology: Toll-like receptors and antibody responses

  2006cited by this paper
• Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.

  2006cited by this paper
• Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery

  2006cited by this paper
• Formation of New Glucomannan−Chitosan Nanoparticles and Study of Their Ability To Associate and Deliver Proteins

  2006cited by this paper
• Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(γ-glutamic acid)

  2006cited by this paper
• The performance of nanocarriers for transmucosal drug delivery

  2006cited by this paper
• Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.

  2006cited by this paper
• Mucosal vaccines: the promise and the challenge

  2006influential reference
• The Combined CTA1-DD/ISCOMs Vector Is an Effective Intranasal Adjuvant for Boosting Prior Mycobacterium bovis BCG Immunity to Mycobacterium tuberculosis

  2006cited by this paper
• A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations.

  2006cited by this paper
• Particulate nanomedicines.

  2006cited by this paper
• Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(gamma-glutamic acid)-graft-L-phenylalanine copolymers.

  2006cited by this paper
• Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.

  2006influential reference
• Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs

  2005cited by this paper
• Immunity in response to particulate antigen-delivery systems.

  2005cited by this paper
• The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.

  2005cited by this paper
• Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.

  2005cited by this paper
• Chitosan and the mucosal delivery of biotechnology drugs.

  2005cited by this paper
• Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.

  2005cited by this paper
• Nanosphere induced gene expression in human dendritic cells.

  2005cited by this paper
• PLA-PEG particles as nasal protein carriers: the influence of the particle size.

  2005influential reference
• Immunotherapy for Alzheimer's Disease and Other Dementias

  2005cited by this paper
• Induction of dendritic cell‐mediated immune responses against HIV‐1 by antigen‐capturing nanospheres in mice

  2005cited by this paper
• A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults

  2005cited by this paper
• A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.

  2005cited by this paper
• Mannose-Containing Molecular Patterns Are Strong Inducers of Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Macrophages1

  2005cited by this paper
• Effective nasal influenza vaccine delivery using chitosan.

  2005cited by this paper
• Bronchus‐ and nasal‐associated lymphoid tissues

  2005cited by this paper
• Nanoparticles as carriers for nasal vaccine delivery

  2005cited by this paper
• AIDS vaccine: Intranasal immunization using inactivated HIV-1-capturing core-corona type polymeric nanospheres.

  2005influential reference
• Formulation aspects of biodegradable polymeric microspheres for antigen delivery.

  2005cited by this paper
• The basics and underlying mechanisms of mucoadhesion.

  2005cited by this paper
• Immunotherapy for Alzheimer's disease and other dementias.

  2005cited by this paper
• The role of branched polyesters and their modifications in the development of modern drug delivery vehicles.

  2005cited by this paper
• PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery.

  2005cited by this paper
• ISCOMATRIX adjuvant for antigen delivery.

  2005cited by this paper
• Transmucosal macromolecular drug delivery.

  2005cited by this paper
• Strong Mucosal and Systemic Immunities Induced by Nasal Immunization with Anthrax Protective Antigen Protein Incorporated in Liposome–Protamine–DNA Particles

  2005cited by this paper
• Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1.

  2004cited by this paper
• NY-ESO-1 Protein Formulated in ISCOMATRIX Adjuvant Is a Potent Anticancer Vaccine Inducing Both Humoral and CD8+ T-Cell-Mediated Immunity and Protection against NY-ESO-1+ Tumors

  2004cited by this paper
• Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation.

  2004cited by this paper
• Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins.

  2004cited by this paper
• Induction of HIV‐specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV‐capturing nanospheres in macaques

  2004cited by this paper
• Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres

  2004cited by this paper
• Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodies.

  2004cited by this paper
• Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine.

  2004influential reference
• Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.

  2004cited by this paper
• Design and characterisation of new nanoparticulate polymer blends for drug delivery

  2004cited by this paper
• Is nose‐to‐brain transport of drugs in man a reality?

  2004cited by this paper
• Novel Chitosan Particles and Chitosan-Coated Emulsions Inducing Immune Response via Intranasal Vaccine Delivery

  2004cited by this paper
• Polymer-coated lipid nanostructures as carriers for oral peptide delivery

  2004cited by this paper
• Chitosan microspheres as a potential carrier for drugs.

  2004cited by this paper
• Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.

  2004influential reference
• PEG-PLA Nanoparticles as Carriers for Nasal Vaccine Delivery

  2004influential reference
• Intranasal influenza vaccine in a working population.

  2004cited by this paper
• PLGA nanoparticles in drug delivery: the state of the art.

  2004cited by this paper
• The Global Vaccination Gap

  2004cited by this paper
• M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.

  2004influential reference
• Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.

  2004cited by this paper
• Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries.

  2003cited by this paper
• Intranasal immunization of humans with Streptococcus mutans antigens.

  2003influential reference
• Innate immunity and biodefence vaccines

  2003cited by this paper
• Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.

  2003influential reference
• Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice

  2003cited by this paper
• HIV Mucosal Vaccine: Nasal Immunization with gp160-Encapsulated Hemagglutinating Virus of Japan-Liposome Induces Antigen-Specific CTLs and Neutralizing Antibody Responses1

  2003influential reference
• Liposomes and ISCOMs.

  2003cited by this paper
• Enhanced: The Need for a Global HIV Vaccine Enterprise

  2003cited by this paper

• Ternary Composite Fibers for Oral Anthocyanin Delivery: The Role of Molecular Synergy in PVA/Gelatin/Pullulan Matrices

  2026cites this paper
• Liposomal simvastatin potentiates intranasal H1N1 influenza subunit vaccine via increasing transcytosis of antigen and submucosal dendritic cell recruitment

  2026cites this paper
• Buccal microneedle-delivered ferritin nanovaccines induce strong respiratory immunity against Pseudomonas aeruginosa.

  2025cites this paper
• Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders

  2025cites this paper
• Beyond the Blood-Brain Barrier: Intranasal Vaccines in Cancer Immunotherapy.

  2025cites this paper
• Mucosal and transdermal delivery strategies for mRNA: Transforming the clinical applications.

  2025cites this paper
• Current advancements in nanoparticles for vaccines and drug delivery for the treatment of tuberculosis.

  2025cites this paper
• Polysaccharides: New Frontiers for Nasal Administration of Medicines

  2025cites this paper
• Advancements in Nanoparticle-Based Adjuvants for Enhanced Tuberculosis Vaccination: A Review

  2024cites this paper
• Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines

  2024cites this paper
• Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges

  2024cites this paper
• Maltodextrin-Nanoparticles as a Delivery System for Nasal Vaccines: A Review Article

  2024cites this paper
• Targeting Immune Cells

  2024cites this paper
• Generation of Broad Protection against Influenza with Di-Tyrosine-Cross-Linked M2e Nanoclusters.

  2024cites this paper
• Particle Nanoarchitectonics for Nanomedicine and Nanotherapeutic Drugs with Special Emphasis on Nasal Drugs and Aging

  2023cites this paper
• Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens

  2023cites this paper
• Nasal delivery as a strategy for the prevention and treatment of COVID-19

  2023cites this paper
• Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs

  2023cites this paper
• Effect of dietary supplementation of vitamin C-loaded chitosan nanoparticles on growth, immune-physiological parameters, and resistance of white shrimp Litopenaeus vannamei to Vibrio harveyi challenge

  2023cites this paper
• pH-Responsive Mucus-Penetrating Nanoparticles for Enhanced Cellular Internalization by Local Administration in Vaginal Tissue.

  2023cites this paper
• Pulmonary Application of Novel Antigen-Loaded Chitosan Nano-Particles Co-Administered with the Mucosal Adjuvant C-Di-AMP Resulted in Enhanced Immune Stimulation and Dose Sparing Capacity

  2023cites this paper
• Semisynthetic Pneumococcal Glycoconjugate Nanovaccine

  2023cites this paper
• Antiviral drug carriers for human immunodeficiency virus

  2023cites this paper
• Enhancement of intranasal mucosal immunization of mucosal vaccines by ultrasonic treatment

  2023cites this paper
• Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics

  2023cites this paper
• Novel Vectors and Administrations for mRNA Delivery.

  2023cites this paper
• Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43

  2023cites this paper
• Nanoparticles and Antiviral Vaccines

  2023cites this paper
• Nanomaterials in tuberculosis DNA vaccine delivery: historical perspective and current landscape

  2022cites this paper
• Rapid Development of a Mucosal Nanoparticle Flu Vaccine by Genetic Engineering of Bacteriophage T4 using CRISPR-Cas

  2022cites this paper
• Nano dimensions/adjuvants in COVID-19 vaccines.

  2022cites this paper
• In vivo fate and intracellular trafficking of vaccine delivery systems

  2022cites this paper
• Healthcare Applications of Nanoemulsions

  2022cites this paper
• Green synthesis and antimicrobial mechanism of nanoparticles: applications in agricultural and agrifood safety.

  2022cites this paper
• Recent Patents on Nasal Vaccines Containing Nanoadjuvants

  2022influential citation
• Oil-in-ionic liquid nanoemulsion-based intranasal delivery system for influenza split-virus vaccine.

  2022cites this paper
• Nano-Vaccination strategies: Applications and Challenges for Intranasal Immunization.

  2022cites this paper
• Therapeutic antibodies – natural and pathological barriers and strategies to overcome them

  2021cites this paper
• Distinct endocytosis and immune activation of poly lactic-co-glycolic acid nanoparticles prepared by single- and double-emulsion evaporation.

  2021cites this paper
• Recent Advances in the Noninvasive Delivery of mRNA.

  2021cites this paper
• Advanced applications of green hydrogels in drug delivery systems

  2021cites this paper
• Polymeric nanotherapeutics acting at special regions of body

  2021cites this paper
• A chitosan-based nanosystem as pneumococcal vaccine delivery platform

  2021cites this paper
• Chitosan Nanoparticles Loaded with Truncated ORF2 Protein as an Oral Vaccine Candidate against Hepatitis E.

  2021cites this paper
• Metal Nanoparticles against Viruses: Possibilities to Fight SARS-CoV-2

  2021cites this paper
• Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis

  2021cites this paper
• Validating CFD predictions of nasal spray deposition: Inclusion of cloud motion effects for two spray pump designs

  2021cites this paper
• Nanotechnologies for the delivery of biologicals: historical perspective and current landscape.

  2021cites this paper
• Particulate carriers for nose-to-brain delivery

  2021cites this paper
• Innovative Therapeutic and Vaccine Approaches against Respiratory Pathogens

  2020cites this paper
• Nanoparticles and Its Implications in HIV/AIDS Therapy.

  2020cites this paper
• Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators

  2020cites this paper
• Nanotechnological strategies for systemic microbial infections treatment: A review

  2020cites this paper
• Intranasal inoculations of naked or PLGA-PEI nanovectored DNA vaccine induce systemic and mucosal antibodies in pigs: A feasibility study.

  2020cites this paper
• Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study

  2020cites this paper
• Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses

  2020cites this paper
• Preparation and characterization of lamotrigine containing nanocapsules for nasal administration.

  2020cites this paper
• Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.

  2020cites this paper
• Self‐Assembled Nanoparticles: Exciting Platforms for Vaccination

  2020cites this paper
• Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases.

  2019cites this paper
• Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections

  2019cites this paper
• Vaccine Lipid-Biopolymer Cross-Linked Nanoparticles Against Infectious Diseases and Cancer

  2019cites this paper
• Characterization and antioxidant activity of short linear glucan–lysine nanoparticles prepared by Maillard reaction

  2019cites this paper
• An overview of the neuroprotective potential of rosmarinic acid and its association with nanotechnology‐based delivery systems: A novel approach to treating neurodegenerative disorders

  2019cites this paper
• Chitosan‐Based Drug Delivery Systems

  2019cites this paper
• How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods

  2019cites this paper
• A REVIEW ON PHYSICO-CHEMICAL PARAMETERS OF LIPOSOMAL DOXORUBICIN

  2019cites this paper
• Nanoparticle-Based Vaccines Against Respiratory Viruses

  2019cites this paper
• Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines

  2019cites this paper
• A SCIENTIFIC REVIEW ON NANOEMULSION FOR TARGETING DRUG DELIVERY SYSTEM

  2019cites this paper
• Nasal route for vaccine and drug delivery: features and current opportunities.

  2019cites this paper
• Protein delivery by porous cationic maltodextrin-based nanoparticles into nasal mucosal cells: Comparison with cationic or anionic nanoparticles

  2018cites this paper
• NANOEMULSION BASED DRUG DELIVERY-A REVIEW

  2018cites this paper
• Fractionation of debranched starch with different molecular weights via edible alcohol precipitation

  2018cites this paper
• Dual-Use Nano-Neurotechnology:

  2018cites this paper
• Polysaccharides as vaccine adjuvants.

  2018cites this paper
• Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections

  2018cites this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cites this paper
• Glucose-responsive biopolymer nanoparticles prepared by co-assembly of concanavalin A and amylopectin for insulin delivery

  2018cites this paper
• Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.

  2018cites this paper
• Distribution of polymer-coated gold nanoparticles in a 3D lung model and indication of apoptosis after repeated exposure.

  2018cites this paper
• Broadly protective nanoparticle-based mucosal vaccine against influenza virus infection

  2018cites this paper
• Micro- and nano-carrier systems: The non-invasive and painless local administration strategies for disease therapy in mucosal tissues.

  2017cites this paper
• IRE1 knockdown modifies the effect of glutamine depreviation on the expression of a subset of proteases in U87 glioma cells

  2017cites this paper
• Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals

  2017cites this paper
• Recent developments in nanocarrier-aided mucosal vaccination.

  2017cites this paper
• NANOEMULSION: DIRECT NOSE-TO-BRAIN DELIVERY

  2017cites this paper
• Uptake and distribution of ultrafine nanoparticles and microemulsions from the nasal mucosa

  2017cites this paper
• Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes.

  2017cites this paper
• Intranasal delivery of nanoparticle-based vaccines.

  2017cites this paper
• Nanomaterials in the Context of Type 2 Immune Responses—Fears and Potentials

  2017cites this paper
• Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation

  2017cites this paper
• Nanoparticulate Immunotherapy: An Intelligent Way to Tailor Make Our Defense System

  2017cites this paper
• Current prospects and future challenges for nasal vaccine delivery

  2017cites this paper
• Nasal nanovaccines.

  2017cites this paper
• Improving chemotherapy drug delivery by nanoprecision tools

  2017cites this paper
• Modulating the immune system through nanotechnology.

  2017cites this paper
• Adjuvant properties of nanoparticles immobilized recombinant diphtheria toxoid fragment

  2017cites this paper
• Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen

  2017cites this paper
• Co-delivery of polyinosinic:polycytidylic acid and flagellin by poly(lactic-co-glycolic acid) MPs synergistically enhances immune response elicited by intranasally delivered hepatitis B surface antigen

  2017cites this paper